Effects of apelin on reproductive functions: relationship with feeding behavior and energy metabolism

Apelin is an adipose tissue derived peptidergic hormone. In this study, 40 male Sprague-Dawley rats were used (four groups; n = 10). Apelin-13 at three different dosages (1, 5 and 50 μg/kg) was given intraperitoneally while the control group received vehicle the same route for a period of 14 days. I...

Full description

Saved in:
Bibliographic Details
Published inArchives of physiology and biochemistry Vol. 123; no. 1; pp. 9 - 15
Main Authors Tekin, Suat, Erden, Yavuz, Sandal, Suleyman, Etem Onalan, Ebru, Ozyalin, Fatma, Ozen, Hasan, Yilmaz, Bayram
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 01.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Apelin is an adipose tissue derived peptidergic hormone. In this study, 40 male Sprague-Dawley rats were used (four groups; n = 10). Apelin-13 at three different dosages (1, 5 and 50 μg/kg) was given intraperitoneally while the control group received vehicle the same route for a period of 14 days. In results, apelin-13 caused significant decreases in serum testosterone, luteinizing hormone and follicle-stimulating hormone levels (p < 0.05). Administration of apelin-13 significantly increased body weights, food intake, serum low-density lipoprotein and total cholesterol levels (p < 0.05), but caused significant decreases in high-density lipoprotein levels (p < 0.05). Serum glucose and triglyceride levels were not significantly altered by apelin-13 administration. Significant decreases in both uncoupling protein (UCP)-1 levels in the white and brown adipose tissues and UCP-3 levels in the biceps muscle (p < 0.05) were noted. The findings of the study suggest that apelin-13 may not only lead to obesity by increasing body weight but also cause infertility by suppressing reproductive hormones.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1381-3455
1744-4160
DOI:10.1080/13813455.2016.1211709